Syeda Nadia Ahmad | Maternal Health | Best Researcher Award

Assist. Prof. Dr. Syeda Nadia Ahmad | Maternal Health | Best Researcher Award 

Assistant Professor | University of Chakwal | Pakistan

Dr. Syeda Nadia Ahmad, Ph.D is a distinguished academic and researcher whose professional journey reflects a sustained commitment to advancing the frontiers of biochemistry, molecular biology, and biomedical sciences. As Chairperson and accomplished faculty member, she has demonstrated exceptional leadership in fostering interdisciplinary collaboration and academic excellence within the life sciences. Her scholarly expertise spans biochemical pathways, molecular therapeutics, and metabolic research, with her work contributing significantly to understanding disease mechanisms and identifying innovative molecular targets for therapeutic development. Dr. Ahmad’s extensive portfolio of peer-reviewed publications in high-impact international journals underscores her scientific rigor and thought leadership, while her citations reflect the global recognition and influence of her research contributions. She has actively collaborated with national and international institutions, promoting translational research that bridges fundamental science with clinical and societal applications. Through her mentorship, Dr. Ahmad has nurtured the next generation of scientists, emphasizing ethical research practices, innovation, and scientific integrity. Her professional endeavors extend beyond academia through participation in conferences, editorial boards, and scientific networks that encourage global dialogue on biomedical advancement and public health innovation. Committed to societal betterment, Dr. Ahmad’s research initiatives align with sustainable health outcomes, targeting complex diseases and improving diagnostic and therapeutic strategies. Her visionary approach integrates scientific inquiry with community well-being, reflecting a balance between research excellence and social responsibility. Widely respected for her intellectual depth, organizational leadership, and dedication to knowledge dissemination, Dr. Syeda Nadia Ahmad continues to make a lasting impact on science, education, and society, embodying the ideals of academic integrity, collaborative progress, and transformative biomedical innovation. She has 71 citations from 39 documents with an h-index of 4.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Ahmad, S. N. (2024, May 23–25). A study on CCl₄-induced pathologies in male mouse testes and the investigation of the healing potential of four medicinal plant fruit extracts. Presented at the 3rd International Veterinary Biochemistry and Clinical Biochemistry Congress (VetBio2024), Van Yüzüncü Yıl University, Faculty of Veterinary Medicine, Department of Biochemistry.

2. Ahmad, S. N. (2024, May 15–16). The ameliorating effects of virgin olive oil in adrenal gland of mice exposed to lambda-cyhalothrin and cypermethrin. Presented at the 1st International Conference on Emerging Trends in Artificial Intelligence and Cyber Security (ICEAC-2024), Khawaja Fareed UEIT RYK.

3. Ahmad, S. N., Ishaq, T., Kanwal, M. A., Inayat, I., Abdullah, U., & Ahmad, K. R. (2024, May 13). Ameliorations of Olea ferruginea fruit pulp extract in CCl₄-induced testicular pathology in mice. Journal of Bioresource Management.

4. Ahmad, S. N. (2024, May 23–25). A study on CCl₄-induced pathologies in male mouse testes and the investigation of the healing potential of four medicinal plant fruit extracts. Presented at the 3rd International Veterinary Biochemistry and Clinical Biochemistry Congress (VetBio2024), Van Yüzüncü Yıl University, Faculty of Veterinary Medicine, Department of Biochemistry.

5. Younis, A., Hussain, I., Ahmad, S. N., Shah, A., Inayat, I., Kanwal, M. A., Suleman, S., Kamran, M. A., Matloob, S., & Ahmad, K. R. (2024, April 26). Validation of Bos taurus SNPs for milk productivity of Sahiwal breed (Bos indicus), Pakistan. Animals.

Dr. Syeda Nadia Ahmad’s pioneering research integrates molecular science with translational medicine, driving innovations that bridge laboratory discoveries to real-world health solutions. Her work advances biomedical knowledge, fosters sustainable therapeutic development, and contributes to global health equity through impactful scientific collaboration and societal engagement.

Ashiquir Rahaman | Mental Health | Best Researcher Award

Mr. MD. Ashiquir Rahaman | Clinical Psychology | Best Researcher Award 

Lecturer | University of Dhaka | Bangladesh

Md. Ashiquir Rahaman is an accomplished academic and clinical psychologist whose professional expertise spans clinical practice, research, and academic instruction, with a strong focus on mental health, neurodevelopmental disorders, and psychosocial well-being. Currently serving as a Lecturer at the Department of Clinical Psychology, University of Dhaka, he has contributed extensively to the advancement of clinical training, supervision, and mental health education. His prior professional experience at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), reflects a deep engagement with HIV prevention, counselling, and mental health support for marginalized populations, underscoring his commitment to public health and human welfare. Over his academic career, he has co-authored numerous research publications in internationally recognized journals such as Frontiers in Genetics, Journal of Autism and Developmental Disorders, Neuropsychological Rehabilitation, BMC Public Health, International Journal for Equity in Health, and Molecular Genetics and Genomic Medicine, among others. His scholarly works address critical topics including autism spectrum disorder, pain management, well-being assessment, and culturally sensitive psychological interventions. In addition to his research, he has been actively involved in national and international academic collaborations, contributing to policy and program development for mental health and behavioral interventions. His leadership as a clinical supervisor and trainer has played a pivotal role in shaping the next generation of psychologists in Bangladesh. A recipient of the Begum Azizun Nesa Memorial Gold Award for academic excellence, he exemplifies intellectual rigor and compassionate practice. Through his integrated approach combining clinical psychology, community engagement, and evidence-based research, Md. Ashiquir Rahaman continues to contribute meaningfully to global mental health discourse, advancing culturally attuned therapeutic practices and promoting psychological resilience within diverse communities. He has 34 citations from 8 documents with an h-index of 3.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Akter, H., Rahman, M. M., Sarker, S., Basiruzzaman, M., Islam, M. M., … (2023). Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. Frontiers in Genetics.

2. Rahman, M. M., Uddin, K. M. F., Al Jezawi, N. K., Karuvantevida, N., Akter, H., … (2019). Gonadal mosaicism of large terminal de novo duplication and deletion in siblings with variable intellectual disability phenotypes. Molecular Genetics & Genomic Medicine.

3. Rahaman, M. A., Lopa, M., Uddin, K. M. F., Baqui, M. A., Keya, S. P., Faruk, M. O., … (2021). An exploration of physical and phenotypic characteristics of Bangladeshi children with autism spectrum disorder. Journal of Autism and Developmental Disorders.

4. Iqbal, Y., Jahan, R., Rahaman, M. A., & Faruk, M. O. (2021). Women’s experiences during COVID-19 in Bangladesh. International Perspectives in Psychology.

5. Jahan, R., Rahaman, M. A., & Das, A. (2024). NGOs working on mental health in Bangladesh. In Mental Health in Bangladesh: From Bench to Community.

Md. Ashiquir Rahaman’s work advances the integration of clinical psychology with public health innovation, enhancing mental health care accessibility and culturally sensitive interventions. His research and community initiatives contribute to improving psychological well-being, reducing stigma, and shaping evidence-based mental health policies in low- and middle-income settings.

Serhat Gürbüz | Clinical Medicine | Best Researcher Award

Dr. Serhat Gürbüz | Clinical Medicine | Best Researcher Award 

Doctor of Medicine | University of Health Sciences | Turkey

Dr. Serhat Gürbüz, MD, MSc, is a distinguished Consultant in Orthopedics and Traumatology at the Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. His professional expertise centers on knee, shoulder, and sports surgery, integrating advanced arthroscopic techniques and evidence-based rehabilitation strategies to restore function and improve patient outcomes. Dr. Gürbüz has contributed substantially to the field through scholarly publications in reputable peer-reviewed and indexed journals, clinical presentations, and collaborative research projects focused on musculoskeletal disorders and joint preservation. His work demonstrates a commitment to combining clinical excellence with translational research, contributing to the evolution of orthopedic surgical standards and innovations in minimally invasive procedures. He has maintained active collaborations with national and international orthopedic research groups and serves as a peer reviewer and academic contributor within the global orthopedic community. Dr. Gürbüz’s clinical practice reflects a deep dedication to advancing patient-centered care, surgical innovation, and academic mentorship, fostering the development of future orthopedic specialists. His academic engagement and research productivity underscore his contribution to scientific knowledge dissemination and the enhancement of evidence-based orthopedic medicine. Through his multidisciplinary collaborations and continuous pursuit of clinical innovation, Dr. Gürbüz has strengthened the bridge between medical research and practical application, ultimately promoting better musculoskeletal health and improving the quality of life for patients across diverse populations. He has 6 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Çelikoyar, M. M., Topsakal, O., & Gürbüz, S. (2019). Mobile technology for recording surgical procedures. Journal of Visual Communication in Medicine.

2. Imren, Y., Karslioglu, B., Dedeoglu, S. S., Cabuk, H., Atar, S., Gürbüz, S., … (2021). The effect of gluteus maximus tenotomy in primary total hip arthroplasty with posterior approach: Kinematic analysis of hip extensor strength. Journal of Orthopaedic Surgery.

3. Yüce, A., Yerli, M., Erkurt, N., Gürbüz, S., Çakar, M., & Adaş, M. (2022). Neutrophil-lymphocyte and C-reactive protein–albumin ratios as predictors of re-surgery in adult native knee septic arthritis. Journal of Clinical and Investigative Surgery.

4. Gürbüz, S., Bahar, H., Yavuz, U., Keskin, A., Karslioglu, B., & Solak, Y. (2025). Comparative efficacy of ChatGPT and DeepSeek in addressing patient queries on gonarthrosis and total knee arthroplasty. Arthroplasty Today.

5. Gürbüz, S., Ocak, O., Kir, M. C., Karslioglu, B., & Aki, S. (2025). Hyperchloremia at hospital admission for hip fractures is related with an increase in morbidity and mortality rates. Turkish Journal of Trauma and Emergency Surgery.

Dr. Serhat Gürbüz’s work advances global orthopedic science through innovative surgical techniques, evidence-based clinical research, and multidisciplinary collaborations that enhance musculoskeletal health. His commitment to patient-centered innovation and translational research contributes significantly to improving mobility, recovery, and quality of life in society worldwide.

Leticia Peris | Neuroscience | Best Researcher Award

Dr. Leticia Peris | Neuroscience | Best Researcher Award 

Inserm researcher | Grenoble Institut of Neurosciences | France

Dr. Leticia Peris is a distinguished neuroscientist and cell biologist whose research focuses on uncovering the molecular mechanisms that regulate the neuronal cytoskeleton and its dysfunction in neurodegenerative diseases. She serves as an Inserm Research Scientist at the Grenoble Institute of Neurosciences (UGA–INSERM U1216, France), where her work has significantly advanced the understanding of tubulin post-translational modifications and their role in neuronal morphogenesis, synaptic integrity, and neurodegeneration. Dr. Peris made pioneering contributions by identifying the tubulin carboxypeptidases VASH1/2–SVBP complex and elucidating their importance in neuronal organization and neurodevelopmental disorders. Her research further demonstrated how dysregulated tubulin modifications contribute to synaptic degeneration in Alzheimer’s disease and revealed new mechanisms of L-Dopa–induced synaptotoxicity in Parkinson’s disease. With an extensive record of publications in high-impact journals, international collaborations, and innovative patents, her work bridges fundamental neuroscience and translational medicine. She actively collaborates with leading researchers across France, Argentina, Germany, and the United States, including teams at Columbia University, Boston Children’s Hospital, and Humboldt University. A member of several international scientific societies and editorial boards, Dr. Peris is also deeply engaged in ethical and ecological initiatives promoting responsible and sustainable scientific practices. Her ongoing projects aim to rejuvenate neuronal cytoskeleton function as a therapeutic strategy against neurodegeneration, making her a leading voice in cellular neurobiology and a key contributor to the global fight against Alzheimer’s and Parkinson’s diseases. She has 2741 citations from 36 documents with an h-index of 24.

Profiles:  Scopus | ORCID

Featured Publications

1. Zorgniotti, A., Sharma, A., Ramirez-Rios, S., Sanyal, C., Aleman, M., Ditamo, Y., Moutin, M. J., Bisig, C. G., & Peris, L. (2024). L-Dopa incorporation into tubulin alters microtubule dynamics and reduces dendritic spine invasion and synapse maintenance [Preprint].

2. Konietzny, A., Han, Y., Popp, Y., van Bommel, B., Sharma, A., Delagrange, P., Arbez, N., Moutin, M. J., Peris, L., & Mikhaylova, M. (2024). Efficient axonal transport of endolysosomes relies on the balanced ratio of microtubule tyrosination and detyrosination. Journal of Cell Science.

3. Konietzny, A., Peris, L., Han, Y., Popp, Y., van Bommel, B., Sharma, A., Delagrange, P., Arbez, N., Moutin, M. J., & Mikhaylova, M. (2023). Efficient axonal trafficking of endolysosomes depends on the balanced ratio of microtubule tyrosination and detyrosination [Preprint].

4. Peris, L. (2022). Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer’s disease. Frontiers in Cell and Developmental Biology.

5. Peris, L. (2022). Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease. Brain: A Journal of Neurology.

Dr. Leticia Peris’s research advances global neuroscience by uncovering cellular mechanisms that drive neurodegenerative diseases, paving the way for innovative therapeutic strategies. Her work bridges fundamental biology and translational medicine, contributing to improved brain health and societal well-being worldwide.

Christianah Ibironke Odita | Epidemiology | Best Researcher Award

Dr. Christianah Ibironke Odita | Epidemiology | Best Researcher Award 

Research Officer | National Veterinary Research Institute, Vom | Nigeria

Dr. Christianah Ibironke Odita is a distinguished Chief Veterinary Research Officer and Head of the Division of Veterinary Public Health and Preventive Medicine at the National Veterinary Research Institute (NVRI), Vom, Nigeria. She holds a Ph.D. in Veterinary Science from the University of Pretoria, South Africa, an M.Sc. in Veterinary Epidemiology and Public Health from the Royal Veterinary College, University of London, and a Master of Veterinary Public Health (MVPH) as well as a Doctor of Veterinary Medicine (DVM) from the University of Ibadan, Nigeria. Her research focuses on the epidemiology and control of infectious and zoonotic diseases, particularly at the human–animal interface, with specialization in disease surveillance, risk modeling, outbreak investigation, and preventive medicine. Dr. Odita has authored and co-authored several impactful publications in reputed journals, including Vaccine, One Health Outlook, Nigerian Veterinary Journal, and Open Veterinary Journal. Her scholarly contributions span critical studies on rabies, avian influenza, anthrax, and antimicrobial resistance in poultry, emphasizing evidence-based strategies for public health policy and disease prevention. She is a Commonwealth Scholar and a recipient of the Epix Analytics One Risk Course Awards for excellence in report writing and presentation, as well as the NVRI Research Grant Award. Dr. Odita continues to contribute to advancing veterinary epidemiology and public health through research, mentorship, and active engagement in collaborative One Health initiatives across Africa. She has 7 citations from 4 documents with an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

1. Akanbi, O. B., Alaka, O. O., Olaifa, O. S., Meseko, C. A., Inuwa, B., Ohore, O. G., Tijani, M., Jarikre, T., Ola, O., & Odita, C., et al. (2024). Pathology and molecular detection of influenza A subtype H9N2 virus in commercial poultry in Nigeria. Open Veterinary Journal.

2. Odita, C. I., Conan, A., Smith-Antony, M., Battice, J., England, S., Barry, D., Gessner, B. D., & Knobel, D. L. (2022). Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial. Vaccine.

3. Knobel, D., Odita, C. I., Conan, A., Barry, D., Smith-Anthony, M., Battice, J., England, S., & Gessner, B. D. (2020). Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: Study protocol for a randomized controlled trial. Trials.

4. Odita, C. I., Conan, A., Barry, D., Smith-Antony, M., Battice, J., England, S., Gessner, B. D., & Knobel, D. (2020). Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: Study protocol for a randomized controlled trial.

Maxim Evstigneev | Pharmacology | Best Researcher Award

Prof. Dr. Maxim Evstigneev | Pharmacology | Best Researcher Award 

Director | Sevastopol State University | Russia

Dr. Maxim Pavlovich Evstigneev is the Director of the Institute for Advanced Studies at Sevastopol State University, Russian Federation. He earned his Ph.D. and Doctor of Science (DrSci) in Biophysics and was later appointed Full Professor of Physics. Dr. Evstigneev’s research focuses on the thermodynamics of drug interactions, biophysical chemistry, and nanoparticle interactions, with pioneering contributions in understanding DNA-binding drug mechanisms and the biomedical potential of C60 fullerenes. He has authored numerous peer-reviewed journal articles and several scientific books, including DNA-binding Aromatic Drug Molecules: Physico-chemical Interactions and Their Biological Roles and Structure, Thermodynamics and Energetics of Drug-DNA Interactions. His scientific impact is reflected through extensive citations and global recognition. Dr. Evstigneev has received multiple prestigious honors, including awards from the Cabinet of Ministers of Ukraine, the President of Ukraine Award to Young Scientists, and recognition as the youngest Doctor of Sciences in Ukraine. He has also led several national and international research grants supported by major scientific foundations and institutions. Beyond research, he serves as Guest Editor for Organic Chemistry International Journal and was an Editorial Board Member of BioMed Research International. Currently, he is Vice-President of the Crimean Academy of Sciences and a recognized expert for the Russian Academy of Sciences, exemplifying leadership and excellence in molecular biophysics and nanomaterials research. He has 2564 citations from 191 documents with an h-index of 28.

Profiles: Google Scholar | Scopus

Featured Publications

1. The Fundamental Origin of the Polar Contribution to Heat Capacity Changes in Hydration in an Aqueous Solution. (2025). Journal of Physical Organic Chemistry.

2. The Correlated States Theory of the Hydrophobic Effect. (2025). Journal of Physical Chemistry B.

3. Valsartan – Choline: Preparation, Characterization, and Transdermal Permeation. (2025). Journal of Molecular Liquids.

4. Rationalizing DLS Size Distributions of Fullerene Conjugates. (2024). Letter Article.

5.New PMMA-Based Hydroxyapatite/ZnFe₂O₄/ZnO Composite with Antibacterial Performance and Low Toxicity. (2023). Biomimetics.

Ayesha Zainab Beg | Infectious Diseases | Best Researcher Award

Dr. Ayesha Zainab Beg | Infectious Diseases | Best Researcher Award 

Post Doctoral Scientist | Columbia University | United States

Dr. Ayesha Zainab Beg is a Postdoctoral Research Scientist in the Department of Pediatrics at Columbia University Irving Medical Center (CUIMC), New York, where she investigates airway host–pathogen interactions with a focus on microbial pathogenesis and immunometabolism. She earned her Ph.D. in Biotechnology from Aligarh Muslim University, India, where her doctoral research elucidated the role of Pseudomonas aeruginosa biofilm components, particularly the functional amyloid Fap, in chronic airway infections and pathoadaptation, leading to seven peer-reviewed publications. She also holds an M.Sc. in Biotechnology and a B.Sc. (Hons.) in Biochemistry from the same institution. Dr. Beg’s current work explores how the cystic fibrosis airway environment drives adaptive genetic alterations in clinical isolates of P. aeruginosa and how airway immunometabolites regulate bacterial proteomes via post-translational modifications. Her research highlights include studies on Fap phosphorylation, multi-epitope vaccine design against functional amyloids, and the impact of bacterial metabolites on pulmonary infections, with recent publications in Journal of Biomolecular Structure and Dynamics, Nature Communications, and Microbiology Spectrum. She has presented her work at major conferences including ATS, Cold Spring Harbor Laboratory, and ECCMID, and has been recognized with multiple fellowships and awards, including the Young Achiever Award  and Research Excellence Award. Her expertise spans molecular microbiology, proteomics, metabolomics, immunoinformatics, and murine models of infection, making her a leading early-career researcher at the interface of host–pathogen interactions and metabolic regulation. She has 153 citations from 10 documents with an h-index of 4.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Alam, P., Beg, A. Z., Siddiqi, M. K., Chaturvedi, S. K., Rajpoot, R. K., Ajmal, M. R., … (2017). Ascorbic acid inhibits human insulin aggregation and protects against amyloid-induced cytotoxicity. Archives of Biochemistry and Biophysics.

2. Beg, A. Z., Farhat, N., & Khan, A. U. (2021). Designing multi-epitope vaccine candidates against functional amyloids in Pseudomonas aeruginosa through immunoinformatic and structural bioinformatics approach. Infection, Genetics and Evolution.

3. Beg, A. Z., Rashid, F., Talat, A., Haseen, M. A., Raza, N., Akhtar, K., Dueholm, M. K. D., … (2023). Functional amyloids in Pseudomonas aeruginosa are essential for the proteome modulation that leads to pathoadaptation in pulmonary niches. Microbiology Spectrum.

4. Beg, A. Z., & Khan, A. U. (2018). Genome analyses of blaNDM-4 carrying ST 315 Escherichia coli isolate from sewage water of one of the Indian hospitals. Gut Pathogens.

5. Beg, A. Z., & Khan, A. U. (2019). Exploring bacterial resistome and resistance dissemination: An approach of whole genome sequencing. Future Medicinal Chemistry.

javad Fahanik babaei | Neuroscience | Best Researcher Award

Dr. javad Fahanik babaei | Neuroscience | Best Researcher Award

Faculty member | Tehran University of Medical Sciences | Iran

Dr. Javad Fahanik Babaei is an accomplished Iranian physiologist currently affiliated with the Iran University of Medical Sciences in Tehran, Iran. He earned his Ph.D. in Physiology by research from the same institution in 2018, following an M.Sc. in Developmental Biology (2005) and a B.Sc. in Botany (2003). His extensive research focuses on neurophysiology, electrophysiology, mitochondrial bioenergetics, neurodegeneration, and the pathophysiological mechanisms underlying Alzheimer’s disease and epilepsy. Dr. Babaei has contributed significantly to the understanding of ion channels, synaptic plasticity, and mitochondrial function, with over 40 peer-reviewed publications in prestigious journals such as Biochimica et Biophysica Acta (BBA), Metabolic Brain Disease, Neurophysiology, Journal of Chemical Neuroanatomy, and Scientific Reports. His studies on the electrophysiological and biochemical effects of compounds like trigonelline, apigenin, and riluzole in experimental models of neurodegenerative and epileptic disorders have been widely recognized. Beyond research, he has served as a referee for the Basic and Clinical Neuroscience Journal (2017–2019) and has been a committee member for national physiology and neuroscience congresses in Iran. Dr. Babaei has also contributed to academia as a translator of several foundational physiology and histology textbooks, including Bern and Levy Physiology. His distinguished work in neuroscience and physiology has positioned him as a key contributor to advancing experimental neurobiology in Iran, particularly in the areas of mitochondrial physiology, electrophysiological methodologies, and translational neuroscience research. He has 627 citations from 66 documents with an h-index of 13.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Erratum to “Cognitive impairments induced by repeated sevoflurane exposure during pre-adolescence in adult male and female rats: Involvement of biochemical, histological and neuroplasticity approaches.” (2023). Journal of Cellular and Molecular Anesthesia.

2. Sex-specific behavioral impairments and neuronal alterations in Wistar rats following repeated sevoflurane exposure during developmental stages. (2025). Neurological Research.

3. Protective effects of licofelone on scopolamine-induced spatial learning and memory impairment by enhancing parkin-dependent mitophagy and promotion of neural regeneration in adult mice. (2024). European Journal of Pharmacology.

4. 40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model. (2024). Scientific Reports.

5. Fasudil attenuates lipopolysaccharide-induced cognitive impairment in C57BL/6 mice through anti-oxidative and anti-inflammatory effects: Possible role of aquaporin-4. (2024). IBRO Neuroscience Reports.

Siyu Chen | Pharmacology | Best Researcher Award

 Prof. Siyu Chen | Pharmacology | Best Researcher Award

Professor | China Pharmaceutical University | China

Dr. Chen Siyu currently serves as the Deputy Director of the Department of Biochemistry at the School of Life Sciences and Technology, China Pharmaceutical University, where he is also a Professor, Doctoral Supervisor, and Chief Young Scientist of the National Key Research and Development Program. He obtained his academic training in biochemistry and molecular biology, cultivating a strong foundation in metabolic and biochemical sciences. Dr. Chen’s research primarily focuses on Target Discovery and Intervention Strategies for Metabolic Diseases, aiming to elucidate molecular mechanisms and identify novel therapeutic targets for metabolic regulation. He has published extensively as first or corresponding author in leading international journals such as Advanced Science, Nature Communications, and Gut Microbes, with his work widely cited by peers. His innovative research has led to the granting of national patents and multiple ongoing patent applications. Dr. Chen has successfully led major research projects under national and provincial funding programs, including the National Key R&D Program for Young Scientists, the National Natural Science Foundation for Young Scientists, and the Jiangsu Province Excellent Youth Fund. Recognized for his scholarly excellence, he received the Outstanding Doctoral Dissertation Award of Jiangsu Province. In addition to his research, Dr. Chen contributes actively to the academic community as a Young Member of the Metabolism Committee of the Chinese Society of Biochemistry, Director of the Jiangsu Society of Developmental Biology, and Editorial Board Member of Journal of China Pharmaceutical University and Progress in Biochemistry and Biophysics. He also serves as a Guest Editor for Frontiers in Endocrinology and a regular reviewer for leading journals including Journal of Hepatology and ACS Nano. He has 1616 citations from 60 documents with an h-index of 24.

Profiles: Scopus | ORCID

Featured Publications

1. Photosensitive biomimetic nanomedicine-mediated recombination of adipose microenvironments for antiobesity therapy. (2025). Advanced Materials.

2. Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity. (2025). Bioengineering and Translational Medicine.

3. Blue light-driven cell cycle arrest in thyroid cancer via Retinal-OPN3 complex. (2024). Cell Communication and Signaling.

4. Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. (2024). EMBO Molecular Medicine.

5. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer. (2024). Phytomedicine.

Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award

Prof. Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award 

Former Vice Chancellor | Utkal University | India

Prof. (Dr.) Pradeep Kumar Chand is a distinguished academician and researcher, currently serving as Chairperson of NAAC Peer Teams constituted by the National Assessment and Accreditation Council (Government of India) and formerly the Vice Chancellor of a State University. He earned his B.Sc. (Botany Hons.) and M.Sc. (Botany) with top distinctions and obtained his Ph.D. in Science from a reputed university in the United Kingdom, specializing in Plant Biotechnology and Genetic Engineering. With over 37 years of teaching and research experience, Prof. Chand’s pioneering contributions encompass plant tissue culture, genetic transformation, somatic hybridization, DNA fingerprinting, biogenic nanotechnology, and phytochemical analysis. He has guided numerous postgraduate research scholars, including several Ph.D. and M.Phil. awardees, and has authored numerous research papers in reputed international and national journals. His work in green nanotechnology and nano-onco-therapeutics has earned wide academic recognition. Prof. Chand has been honored with prestigious fellowships from organizations such as the DBT, DST, and INSA, and has served as a Biotechnology Overseas Associate under the Government of India’s Department of Biotechnology. His research collaborations with globally recognized institutions in Europe, Asia, and the United States highlight his international scientific engagement. Additionally, Prof. Chand has held editorial and peer-review roles in several scientific journals, contributing significantly to advancing research standards in biotechnology and plant sciences both nationally and internationally. He has 2333 citations from 81 documents with an h-index of 27.

Profiles: Google Scholar | Scopus

Featured Publications

1. Genetically transformed root extracts of medicinal plant Sida acuta Burm.f. attenuate hyperglycemic effects in induced diabetic rats. (2025). Plant Cell, Tissue and Organ Culture.

2. Validation of PCR amplicon-based directed amplified minisatellite DNA (DAMD) markers for analysis of population structure and fruit trait association of promising Indian mangoes. (2025). Genetic Resources and Crop Evolution.

3. Hexavalent chromium bioaccumulation mediated enhancement of pyrethrin production in African marigold (Tagetes erecta L.): a promising plant for phytoremediation. (2023). Acta Physiologiae Plantarum.

4. Silver nanocrystals bio-fabricated using Rhizobium rhizogenes-transformed in vitro root extracts demonstrate health proactive properties. (2022). Bionanoscience.

5. Anthropogenic interventions regulate forest structure and carbon stock in transitional dry forests of Similipal Biosphere Reserve, India. (2022). Ecoscience.